Publications by authors named "David Bostwick"

Claim this Profile
T
The consensus conference: pitfalls and problems.
Brett Delahunt, Hemamali Samaratunga, David Bostwick, Lars Egevad

Virchows Arch· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase II Clinical Trial of Multiplex IntraTumoral Immunotherapy (MITI) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial).
David G Bostwick, Melanie M Wilk, Brian R Bostwick, Norman Miller, Eugene C Rajaratnam

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients.
Hemamali Samaratunga, Lars Egevad, John Yaxley, Joanna Perry-Keene, Ian Le Fevre, David Bostwick

Pathology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer.
Richard Black, Jelle Barentsz, David Howell, David G Bostwick, Stephen B Strum

Diagnostics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade prostate cancer should still be labelled cancer.
Kenneth A Iczkowski, Mariel Molina, Lars Egevad, David G Bostwick, Geert J L H van Leenders

BJU Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer grading, time to go back to the future.
Lars Egevad, Brett Delahunt, David G Bostwick, Liang Cheng, Andrew J Evans

BJU Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic stromal proliferations: a review.
David G Bostwick, Lars Egevad

Pathology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading.
Lars Egevad, Daniela Swanberg, Brett Delahunt, Peter Ström, Kimmo Kartasalo, David G Bostwick

Virchows Arch· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Hemamali Samaratunga, Brett Delahunt, Lars Egevad, John R Srigley, Athanase Billis, David G Bostwick

Pathology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Peter Ström, Kimmo Kartasalo, Henrik Olsson, Leslie Solorzano, Brett Delahunt, David G Bostwick

Lancet Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Lars Egevad, Brett Delahunt, Daniel M Berney, David G Bostwick, John Cheville

Histopathology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Charlotte F Kweldam, Daan Nieboer, Ferran Algaba, Mahul B Amin, Dan M Berney, David G Bostwick

Histopathology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance genes and modelling of treatment failure in bacterial vaginosis: clinical study of 289 symptomatic women.
David G Bostwick, John Woody, Courtney Hunt, William Budd

J Med Microbiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
Daniel M Moreira, David G Bostwick, Gerald L Andriole, Bercedis L Peterson, Harvey J Cohen

J Urol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary β2-Microglobulin Is a Good Indicator of Proximal Tubule Injury: A Correlative Study with Renal Biopsies.
Xu Zeng, Deloar Hossain, David G Bostwick, Guillermo A Herrera, Ping L Zhang

J Biomark· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing prostate specimen handling for diagnosis and prognosis.
David G Bostwick, Christina E Day, Isabelle Meiers

Methods Mol Biol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
David G Bostwick, Deloar Hossain

Diagn Cytopathol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Kenneth A Iczkowski, Lars Egevad, Jun Ma, Nicholas Harding-Jackson, Ferran Algaba, David G Bostwick

Ann Diagn Pathol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and analysis of Gleason score 8-10 prostate cancers in the REDUCE study.
Gerald L Andriole, David G Bostwick, Leonard G Gomella, Michael Marberger, Francesco Montorsi

Urology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participation of functionally active plasma cells in acute rejection and response to therapy in renal allografts.
Zeenat Yousuf Bhat, David G Bostwick, Deloar Hossain, Xu Zeng

DNA Cell Biol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.
Leonard N Chen, Rachel S Rubin, Eugide Othepa, Caroline Cer, Elizabeth Yun, David G Bostwick

Prostate· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does polyomavirus infection interfere with bladder cancer fluorescence in situ hybridization?
Deloar Hossain, David Hull, Fatemeh Kalantarpour, Rebecca Maitlen, Junqi Qian, David G Bostwick

Diagn Cytopathol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides.
Kenneth A Iczkowski, Kathleen C Torkko, R Storey Wilson, M Scott Lucia, David G Bostwick

Hum Pathol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
Kyung Park, James T Dalton, Ramesh Narayanan, Christopher E Barbieri, Michael L Hancock, David G Bostwick

J Clin Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial.
M Scott Lucia, David G Bostwick, Matthew C Somerville, Ivy L Fowler, Roger S Rittmaster

Arch Pathol Lab Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis